We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$45.1M
1-Year Est. Return
74.25%
This Fund
S&P 500
This Quarter
Est. Return
+5.54%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$173M
AUM Growth
+$73.3M
(+73%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
6.67%
Top 10 Holdings %
Top 10 Hldgs %
96.13%
Holding
83
New
26
Increased
11
Reduced
13
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vivani Medical
VANI
|
+$3.94M |
| 2 |
FMTO
Femto Technologies Inc. Common Stock
FMTO
|
+$2.65M |
| 3 |
Eltek
ELTK
|
+$1.68M |
| 4 |
RDHL
Redhill Biopharma
RDHL
|
+$1.65M |
| 5 |
Global Mofy Metaverse
GMM
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MMAT
Meta Materials Inc. Common Stock
MMAT
|
+$904K |
| 2 |
Phunware
PHUN
|
+$821K |
| 3 |
Cyngn
CYN
|
+$507K |
| 4 |
Treasure Global
TGL
|
+$426K |
| 5 |
DUO
Fangdd Network Group
DUO
|
+$392K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.65% |
| 2 | Technology | 1.24% |
| 3 | Materials | 0.46% |
| 4 | Industrials | 0.37% |
| 5 | Energy | 0.24% |
Similar funds
CG
OC
ICCON
PCM
CAS
CM
MCMC
AB
Sabby Management's Q1 2024 Portfolio in Review
As of Q1 2024, Sabby Management held 83 positions worth $173M, up 73% from $100M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Sabby Management deployed $11.6M of net new capital in Q1 2024, opening 26 new positions and adding to 11 existing holdings. Its largest new stake was Vivani Medical: 2,673,018 shares worth $4.95M.
By sector, the portfolio is most concentrated in Healthcare at 5.6% of assets, up from 3.8% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was Akari Therapeutics, an estimated $279K trimmed.
- Sabby Management's largest Q1 2024 buy was Vivani Medical: 2,673,018 shares worth $4.95M.
- Sabby Management added most to Femto Technologies Inc. Common Stock in Q1 2024, an estimated $2.65M increase.
- Sabby Management's biggest Q1 2024 reduction was Akari Therapeutics, cutting an estimated $279K.
- Sabby Management fully exited Meta Materials Inc. Common Stock in Q1 2024, selling an estimated $904K.
- Sabby Management's ten largest holdings make up 96% of its $173M portfolio in Q1 2024.
- Sabby Management opened 26 new positions and closed 29 in Q1 2024.
- Sabby Management's portfolio value rose 73% quarter-over-quarter to $173M.
Based on Sabby Management's 13F filing for Q1 2024, filed 15 May 2024.